Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Page 1
Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup.
Allodji RS, Hawkins MM, Bright CJ, Fidler-Benaoudia MM, Winter DL, Alessi D, Fresneau B, Journy N, Morsellino V, Bárdi E, Bautz A, Byrne J, Feijen ELA, Teepen JC, Vu-Bezin G, Rubino C, Garwicz S, Grabow D, Gudmundsdottir T, Guha J, Hau EM, Jankovic M, Kaatsch P, Kaiser M, Linge H, Muraca M, Llanas D, Veres C, Øfstaas H, Diallo I, Mansouri I, Ronckers CM, Skinner R, Terenziani M, Wesenberg F, Wiebe T, Sacerdote C, Jakab Z, Haupt R, Lähteenmäki P, Zaletel LZ, Kuehni CE, Winther JF, Michel G, Kremer LCM, Hjorth L, Haddy N, de Vathaire F, Reulen RC. Allodji RS, et al. Among authors: guha j. Eur J Cancer. 2019 Aug;117:71-83. doi: 10.1016/j.ejca.2019.05.013. Epub 2019 Jun 28. Eur J Cancer. 2019. PMID: 31260818
BACKGROUND: Survivors of childhood cancers are at risk of developing subsequent primary leukaemias (SPLs), but the long-term risks beyond 20 years of treatment are still unclear. We investigated the risk of SPLs in five-year childhood cancer survivors using a large-scale p …
BACKGROUND: Survivors of childhood cancers are at risk of developing subsequent primary leukaemias (SPLs), but the long-term risks be …
Risk stratification of childhood cancer survivors necessary for evidence-based clinical long-term follow-up.
Frobisher C, Glaser A, Levitt GA, Cutter DJ, Winter DL, Lancashire ER, Oeffinger KC, Guha J, Kelly J, Reulen RC, Hawkins MM. Frobisher C, et al. Among authors: guha j. Br J Cancer. 2017 Nov 21;117(11):1723-1731. doi: 10.1038/bjc.2017.347. Epub 2017 Oct 24. Br J Cancer. 2017. PMID: 29065109 Free PMC article.
CONCLUSIONS: Despite its simplicity the risk stratification tool provides clear and strong discrimination between survivors assigned to different NCSI Levels in terms of long-term cumulative and excess risks of serious adverse outcomes....
CONCLUSIONS: Despite its simplicity the risk stratification tool provides clear and strong discrimination between survivors assigned to diff …
Risk of Subsequent Bone Cancers Among 69 460 Five-Year Survivors of Childhood and Adolescent Cancer in Europe.
Fidler MM, Reulen RC, Winter DL, Allodji RS, Bagnasco F, Bárdi E, Bautz A, Bright CJ, Byrne J, Feijen EAM, Garwicz S, Grabow D, Gudmundsdottir T, Guha J, Haddy N, Jankovic M, Kaatsch P, Kaiser M, Kuonen R, Linge H, Maule M, Merletti F, Øfstaas H, Ronckers CM, Skinner R, Teepen J, Terenziani M, Vu-Bezin G, Wesenberg F, Wiebe T, Jakab Z, Haupt R, Lähteenmäki P, Zaletel LZ, Kuehni CE, Winther JF, de Vathaire F, Kremer LC, Hjorth L, Hawkins MM. Fidler MM, et al. Among authors: guha j. J Natl Cancer Inst. 2018 Feb 1;110(2). doi: 10.1093/jnci/djx165. J Natl Cancer Inst. 2018. PMID: 28954302 Free article.
These results provide novel, reliable, and unbiased information about risks and risk factors among long-term survivors of childhood and adolescent cancer....
These results provide novel, reliable, and unbiased information about risks and risk factors among long-term survivors of childhood a …
Risk of Cerebrovascular Events in 178 962 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The TYACSS (Teenage and Young Adult Cancer Survivor Study).
Bright CJ, Hawkins MM, Guha J, Henson KE, Winter DL, Kelly JS, Feltbower RG, Hall M, Cutter DJ, Edgar AB, Frobisher C, Reulen RC. Bright CJ, et al. Among authors: guha j. Circulation. 2017 Mar 28;135(13):1194-1210. doi: 10.1161/CIRCULATIONAHA.116.025778. Epub 2017 Jan 25. Circulation. 2017. PMID: 28122884 Free PMC article.
This is the largest-ever cohort study to evaluate the risks of hospitalization for a cerebrovascular event among long-term survivors of teenage and young adult cancer. METHODS: The population-based TYACSS (Teenage and Young Adult Cancer Survivor Study) (N=178,962) was link …
This is the largest-ever cohort study to evaluate the risks of hospitalization for a cerebrovascular event among long-term survivors …
Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The Teenage and Young Adult Cancer Survivor Study.
Henson KE, Reulen RC, Winter DL, Bright CJ, Fidler MM, Frobisher C, Guha J, Wong KF, Kelly J, Edgar AB, McCabe MG, Whelan J, Cutter DJ, Darby SC, Hawkins MM. Henson KE, et al. Among authors: guha j. Circulation. 2016 Nov 15;134(20):1519-1531. doi: 10.1161/CIRCULATIONAHA.116.022514. Epub 2016 Nov 7. Circulation. 2016. PMID: 27821538 Free PMC article.
BACKGROUND: Survivors of teenage and young adult cancer are acknowledged as understudied. Little is known about their long-term adverse health risks, particularly of cardiac disease that is increased in other cancer populations where cardiotoxic treatments have been used. …
BACKGROUND: Survivors of teenage and young adult cancer are acknowledged as understudied. Little is known about their long-term adver …
Long-term adverse outcomes in survivors of childhood bone sarcoma: the British Childhood Cancer Survivor Study.
Fidler MM, Frobisher C, Guha J, Wong K, Kelly J, Winter DL, Sugden E, Duncan R, Whelan J, Reulen RC, Hawkins MM. Fidler MM, et al. Among authors: guha j. Br J Cancer. 2015 Jun 9;112(12):1857-65. doi: 10.1038/bjc.2015.159. Epub 2015 May 19. Br J Cancer. 2015. PMID: 25989269 Free PMC article.
BACKGROUND: With improved survival, more bone sarcoma survivors are approaching middle age making it crucial to investigate the late effects of their cancer and its treatment. We investigated the long-term risks of adverse outcomes among 5-year bone sarcoma survivors withi …
BACKGROUND: With improved survival, more bone sarcoma survivors are approaching middle age making it crucial to investigate the late effects …